Progressive decrease of phosphocreatine, creatine and creatine kinase in skeletal muscle upon transformation to sarcoma
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
In vertebrates, phosphocreatine and ATP are continuously interconverted by the reversible reaction of creatine kinase in accordance with cellular energy needs. Sarcoma tissue and its normal counterpart, creatine‐rich skeletal muscle, are good source materials to study the status of creatine and creatine kinase with the progression of malignancy. We experimentally induced sarcoma in mouse leg muscle by injecting either 3‐methylcholanthrene or live sarcoma 180 cells into one hind leg. Creatine, phosphocreatine and creatine kinase isoform levels decreased as malignancy progressed and reached very low levels in the final stage of sarcoma development; all these parameters remained unaltered in the unaffected contralateral leg muscle of the same animal. Creatine and creatine kinase levels were also reduced significantly in frank malignant portions of human sarcoma and gastric and colonic adenocarcinoma compared with the distal nonmalignant portions of the same samples. In mice, immunoblotting with antibodies against cytosolic muscle‐type creatine kinase and sarcomeric mitochondrial creatine kinase showed that both of these isoforms decreased as malignancy progressed. Expressions of mRNA of muscle‐type creatine kinase and sarcomeric mitochondrial creatine kinase were also severely downregulated. In human sarcoma these two isoforms were undetectable also. In human gastric and colonic adenocarcinoma, brain‐type creatine kinase was found to be downregulated, whereas ubiquitous mitochondrial creatine kinase was upregulated. These significantly decreased levels of creatine and creatine kinase isoforms in sarcoma suggest that: (a) the genuine muscle phenotype is lost during sarcoma progression, and (b) these parameters may be used as diagnostic marker and prognostic indicator of malignancy in this tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950
Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., & Eppenberger, H. M. (1992) · Biochemical Journal · doi:10.1042/bj2810021 · Cited by 2,011
Self-citationInhibition of rate of tumor growth by creatine and cyclocreatine
Miller, E. E., Evans, A. E., & Cohn, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3304 · Cited by 82
Cited by
Metabolic Basis of Creatine in Health and Disease: A Bioinformatics-Assisted Review
Bonilla, D. A., Kreider, R. B., Stout, J. R., Forero, D. A., Kerksick, C. M., Roberts, M. D., & Rawson, E. S. (2021) · Nutrients · doi:10.3390/nu13041238 · Cited by 223
Patra, S., Ghosh, A., Roy, S. S., Bera, S., Das, M., Talukdar, D., Ray, S., Wallimann, T., & Ray, M. (2012) · Amino Acids · doi:10.1007/s00726-011-0974-3 · Cited by 64
Exploratory studies of the potential anti-cancer effects of creatine
Campos-Ferraz, P. L., Gualano, B., das Neves, W., Andrade, I. T., Hangai, I., Pereira, R. T. S., Bezerra, R. N., Deminice, R., Seelaender, M., & Lancha, A. H. (2016) · Amino Acids · doi:10.1007/s00726-016-2180-9 · Cited by 47
Deminice, R., Cella, P. S., Padilha, C. S., Borges, F. H., da Silva, L. E. C. M., Campos-Ferraz, P. L., Jordao, A. A., Robinson, J. L., Bertolo, R. F., Cecchini, R., et al. (2016) · Amino Acids · doi:10.1007/s00726-016-2172-9 · Cited by 37
“It has previously been shown that both the creatine content and activity of creatine kinase (CK) progressively decreases during the progression of malignancy in the muscle of mice inoculated with Ehrlich ascites carcinoma (EAC) and live sarcoma 180 cells (Patra et al. 2008, 2012).”
BackgroundCreatine supplementation with methylglyoxal: A potent therapy for cancer in experimental models
Pal, A., Roy, A., & Ray, M. (2016) · Amino Acids · doi:10.1007/s00726-016-2224-1 · Cited by 15
Metadata
- Authors
- Patra, S., Bera, S., SinhaRoy, S., Ghoshal, S., Ray, S., Basu, A., Schlattner, U., Wallimann, T., & Ray, M.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2008-06
- Volume
- 275
- Issue
- 12
- Pages
- 3236-3247
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W1511593813
- Cited by
- 52
- References
- 4
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Progressive decrease of phosphocreatine, creatine and creatine kinase in skeletal muscle upon transformation to sarcoma. https://app.cochat.ai/papers/10.1111/j.1742-4658.2008.06475.x
- The paper
- Patra, S., Bera, S., SinhaRoy, S., Ghoshal, S., Ray, S., Basu, A., Schlattner, U., Wallimann, T., & Ray, M. (2008). Progressive decrease of phosphocreatine, creatine and creatine kinase in skeletal muscle upon transformation to sarcoma. The FEBS Journal. https://doi.org/10.1111/j.1742-4658.2008.06475.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.